SMStanislav M. Minin

Stanislav M. Minin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Stanislav M. Minin has a total of 104 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Detection of Relapses of Glial Brain Tumors Using Quantification of Single-Photon Emission Computed Tomography with 99mTc Technetril and of Perfusion Magnetic Resonance Imaging in Arterial Spin Labelling Mode

    by Wladimir Yu. Ussov, Ilya S. Karabanov, Stanislav M. Minin, Andrey A. Tulupov, Li YongPing, Zhanat Zh. Anashbaev, Pavel A. Semin, Shan YaMing, N. A. Nikitin, Evgenii S. Polovnikov, et al.

    The aim of the study was to quantify and compare the parameters of cerebral tumor blood flow in neuro-oncological neurosurgical patients with relapse-free course and recurrence of glial low-grade tumors using SPECT-CT with 99m Tc-Technetril as a tumorotropic radiopharmaceutical, and MRI in the arterial spin labelling (ASL) mode. Materials and methods. The study included 23 patients treated 2019-2020 with glial brain tumors (15 with grade 2‒4 anaplasia gliomas and 8 with glioblastomas). Of these, 16 with glial brain tumors (13 — gliomas and 3 — glioblastomas) after radical tumor removal followed by external gamma therapy, and 7 with inoperable formations were examined after chemoradiotherapy, without surgical removal. The patients were divided into groups 1 — with a relapse-free course, 11 people; of those who had a relapse/continued growth, 12 patients (group 2), five of them died during a two-year follow-up. All underwent MRI of the brain (MRI 3.0 T) in ASL mode with calculation of cerebral blood flow in absolute units — as ml/min/100 cm3, as well as SPECT-CT with 99m Tc-Technetril on a gamma camera with the ability to determine standardized uptake values (SUV), with calculation of blood flow in tumor formations ( РКрОп ОФЭКТ ), using the method KML (Krivonogov-Minin-Lishmanov), as РКрОп ОФЭКТ = СВП 99mTc-Технетрил * (МО/Body Weight) * 100, where СВП 99mTc-Технетрил is the standardized value of rfp uptake, MO is the minute volume, 100 is the conversion coefficient for representing the result in the usual units “ml/min/100 cm 3 of tissue”. Results. ASL MRI and SPECT-CT with 99m Tc-Technetril methods significantly correlate with each other and are interchangeable in terms of the obtained values of blood flow of malignant tumors, both maximum and average in the studied regions. If there is a visual nodular structure in the area of the removed brain tumor, and blood flow anywhere within it is more than 23 ml/min/ 100 cm 3 , the presence of continued growth or recurrence of a low-grade glial neoplasm is likely. Conclusion. As follows from the presented visual-semiotic and computational data of ASL MRI and SPECT CT with 99m Tc-Technetril, these methods should reasonably be used as widely as possible for early monitoring of the postoperative condition in patients after radical removal of glial low-grade brain tumors. It is advisable to further their comparative and joint study, including in inter-center studies.

  • Open Access

    Pharmacological test with nitroglycerin in combination with perfusion SPECT with 99mTc-Technetril in assessing the viability of ischemic myocardium in patients after acute infarction

    by S. M. Minin, O. Ya. Vasiltseva, I. L. Bukhovets, Z. Zh. Anashbaev, Yu. B. Lishmanov, E. A. Ivanovskaya, V. Yu. Ussov, A. M. Cherniavskii, О. Я. Васильцева, В. Ю. Усов

    Aim. To evaluate the possibility of using nitroglycerin sublingually in combination with 99mTc-Technetril cardiac perfusion single-photon emission computed tomography (SPECT) as a test for detecting viable myocardium. Material and methods. 28 male patients with coronary heart disease (CHD) and postinfarction cardiosclerosis were examined. Group 1 included 10 patients with CHD without signs of acute myocardial infarction (AMI). Group 2 comprised 18 patients with CHD, postinfarction cardiosclerosis (PICS). The control group consisted of patients who were subsequently rejected a diagnosis of CHD. Patients took 2 tablets (1 mg) of nitroglycerin sublingually, and then, at the peak of the drug’s action (after 3–5 minutes), they were intravenously administered 370 MBq of 99mTc-Technetril (by Diamed, Russia). Myocardial SPECT with 99mTc-Technetril was performed 1 hour after RFP injection. The next day, myocardial SPECT with 99mTc-Technetril was repeated at rest. Results. When taking tableted nitroglycerin at a dose of 1 mg sublingually, its maximum plasma concentration is on average 0.26 ± 0.04 microcgram/l. It is reached by 110–150 s, then maintained within 10 % of the maximum for 7-9 minutes. Nitroglycerin leads to improvement in global and local contractility and increased LV pumping function in CHD patients. This is most pronounced in individuals with a higher class of angina pectoris after AMI and major changes in intracardiac hemodynamics initially. The nitroglycerin test in combination with 99mTc-Technetril SPECT-CT allowed to identify myocardial areas with improved blood flow and increased EFLV after CABG. Conclusion. The nitroglycerin test in combination with 99mTc-Technetril SPECT-CT is effective for detecting viable myocardium in patients with coronary atherosclerosis and CHD, safe and relatively simple due to the sublingual route of nitroglycerin intake.

  • Open Access

    Potentials of computer simulation of lung tumors in comparison with 99mТс-MIBI SPECT/CT data

    by N. V. Denisova, M. A. Gurko, S. M. Minin, Zh. Zh. Anashbaev, A. A. Zheravin, E. A. Samoilova, С. Э. Красильников

    The aim of the study was to develop and validate a software package (SP) for computer simulation of the procedure for examining patients with lung cancer by SPECT/CT and assessing the accuracy of reconstruction of tumor lesions.Material and Methods. Lung scintigraphy for a patient with peripheral squamous cell carcinoma of the upper lobe of the right lung was performed using a two-detector gamma camera GE Discovery NM/CT 670 DR (USA) with high-resolution collimators for an energy of 140 KeV and a radiopharmaceutical (RP) 99mTc-Technetril (MIBI, Diamed, Moscow). The data obtained were subjected to computer processing using a specialized Xeleris 4.0 system from GE (USA). The SP included a program for generating a voxel phantom (“virtual patient”), a program for modeling the “raw” data acquisition (“virtual tomograph”) and an image reconstruction based on the OSEM algorithm (Ordered Subset Expectation Maximization). In order to validate the created SP, computer simulation of the above clinical case was performed. The semi-quantitative comparative image analysis was based on a tumor/background score.Results. There was a good correlation between clinical “raw” data recorded from a real patient and projection data calculated by the Monte Carlo method from a “virtual patient”. The results of the comparative analysis showed that the tumor/background assessment was underestimated in the reconstructed images.Conclusion. The problem of the accuracy of the tumor lesions reconstruction by using standard OSEM reconstruction algorithms has not been studied. This issue is important in the management of patients with tumor lesions of the lungs and requires study and systematization. The SP will be used in further studies to analyze errors and artifacts in images of tumor lesions, as well as to develop approaches to overcome them.


  • Open Access

    Current status of nuclear cardiology in the Russian Federation

    by K. V. ZavadovskyZavadovsky, Zh. V. Vesnina, Zh. Zh. Anashbaev, A. V. Mochula, S. I. Sazonova, Yu. N. Ilyushenkova, V. V. Shipulin, Yu. V. Varlamova, A. A. Ansheles, I. P. Aslanidi, et al.

    The article is devoted to the analysis of the current status of nuclear cardiology in the Russian Federation. The data on the number of facilities performing radionuclide investigations for the diagnosis and monitoring of the treatment of cardiovascular diseases, their staffing and equipment are given. The statistics of the conducted nuclear cardiology tests for 2018-2020 are given, as well as their methods, features and diagnostic significance are described.


  • Open Access

    Current status of nuclear cardiology in the Russian Federation

    by K. V. ZavadovskyZavadovsky, Zh. V. Vesnina, Zh. Zh. Anashbaev, A. V. Mochula, S. I. Sazonova, Yu. N. Ilyushenkova, V. V. Shipulin, Yu. V. Varlamova, A. A. Ansheles, I. P. Aslanidi, et al.

    The article is devoted to the analysis of the current status of nuclear cardiology in the Russian Federation. The data on the number of facilities performing radionuclide investigations for the diagnosis and monitoring of the treatment of cardiovascular diseases, their staffing and equipment are given. The statistics of the conducted nuclear cardiology tests for 2018-2020 are given, as well as their methods, features and diagnostic significance are described.

  • Open Access

    Radiomic phenotype of epicardial adipose tissue in the prognosis of atrial fibrillation recurrence after catheter ablation in patients with lone atrial fibrillation

    by Julia Ilyushenkova, Svetlana Sazonova, Evgeny Popov, Konstantin Zavadovsky, Roman Batalov, Evgeny Archakov, Tatyana Moskovskih, Sergey Popov, Stanislav Minin, Alexander Romanov

    Background: Epicardial adipose tissue (EAT) has been considered as one of the probable triggers of atrial fibrillation (AF). CT‐rediomics is a perspective noninvasive method of assessment of EAT. We evaluate the radiomic phenotype of EAT in patients with lone AF in the prognosis of AF recurrence after catheter ablation.Methods: A total of 43 patients with lone AF referred for CA and 20 out‐hospital patients without arrhythmia underwent multidetector computed tomography coronary angiography. Segmentation of EAT and extraction radiomic features were performed on calcium scoring series using by 3D‐Slicer. Clinical follow‐up was performed for 12 months period after the CA.Results: EAT in patients with lone AF had a distinct radiomic phenotype. Thus, 45 of 93 calculated radiomic features, volume and attenuation of EAT were significantly different between patients with lone AF and persons without any arrhythmia. In addition, 17 radiomic features were significantly different in subgroups with and without AF recurrence. Multivariate regression analysis demonstrated that only gray level nonuniformity normalized (GLSZM) was an independent predictor of AF recurrence (OR 1.0027, 95%CI 1.0009–1.0044, p = 0.002). ROC analysis data showed that GLSZM >1227.4 indicates high probability of AF recurrence during 12 months (sensitivity 89.4%, specificity 70.8%, AUC: 0.809; p = 0.001).Conclusion: The radiomic parameter GLSZM is associated with late AF recurrence after CA in patients with lone AF. In current study GLSZM was a stronger predictor of lone AF recurrence in multivariate analysis comparing with other established risk factors and EAT volume and attenuation.


  • Open Access

    The role of cardiac biomarkers and epicardial fat in the diagnosis of heart failure in patients with various types of atrial fibrillation

    by D. V. Losik, E. V. Fisher, I. L. Mikheenko, N. A. Nikitin, S. M. Minin, V. V. Beloborodov, A. B. Romanov

    Aim. To assess the level of various cardiac biomarkers and the volume of epicardial adipose tissue (EAT) in patients with heart failure (HF) depending on the type of atrial fibrillation (AF).Material and methods. This prospective observational study included 69 patients with symptomatic AF, as well as with manifestations of New York Heart Association (NYHA) class II-III HF. All patients were examined before catheter ablation for AF. The following investigations were performed: echocardiography, computed tomography, myocardial perfusion scintigraphy, immunochemical analysis of cardiac biomarkers (brain natriuretic peptide (BNP), high-sensitivity troponin I (hs-TnI)), as well as biochemical analysis of high-sensitivity C reactive protein (hsCRP). Patients were divided into 2 groups, depending on the AF type, into paroxysmal and non-paroxysmal (persistent and long-standing persistent).Results. The analysis included 69 patients with various AF types and symptomatic HF. There were significantly more patients with HF confirmed by an elevated BNP level in the group with non-paroxysmal type (27 (71%) vs 5 (16%), pConclusion. The type of AF plays a role in the interpretation of cardiac specific enzymes, and BNP levels and EAT volume are higher in patients with the non-paroxysmal form.


  • Open Access

    Influence of characteristics of epicardial adipose tissue and myocardial sympathetic innervation on the development of late recurrence of atrial fibrillation after radiofrequency ablation

    by Yu. V. Varlamova, S. I. Sazonova, E. V. Popov, R. E. Batalov, T. V. Moskovskikh, S. V. Popov, S. M. Minin, A. B. Romanov

    Aim. To investigate the relationship between radiological characteristics of epicardial adipose tissue (EAT) and myocardial sympathetic activity, as well as to study their association with late recurrence of atrial fibrillation (AF) after radiofrequency ablation (RFA).Material and methods. This prospective study included 26 people with persistent and long-standing persistent AF scheduled for interventional AF treatment. Before the RFA procedure, all patients underwent cardiac 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy to assess the myocardial sympathetic innervation and contrast-enhanced cardiac multislice computed tomography to assess pulmonary vein anatomy, left atrial volume, and EAT volume. Clinical follow-up, including 12-lead electrocardiography (ECG) and 24-hour ECG monitoring, was carried out 3, 6 and 12 months after RFA.Results. After the end of follow-up, the patients were divided into two groups: with AF recurrence (group 1, n=8) and without AF recurrence (group 2, n=18). Multivariate logistic analysis found that only the 123I-MIBG washout rate (odds ratio, 1,0943; 95% confidence interval, 1,0138-1,1812) proved to be an independent predictor of late AF recurrence after RFA. ROC analysis revealed that a 123I-MIBG washout rate >21% with a sensitivity of 75% and a specificity of 83,3% (AUC=0,844; pConclusion. Parameters of myocardial sympathetic activity, assessed by 123I-MIBG myocardial scintigraphy, are associated with late AF recurrence after RFA in patients with persistent and long-standing persistent AF. There were no reliable data confirming associations between myocardial sympathetic innervation and radiological EAT indicators, as well as the effect of the latter on the risk of AF recurrence after RFA.


  • Open Access

    The role of epicardial adipose tissue and autonomic nervous system in pathophysiology of cardiac arrhythmias

    by Д. В. Лосик, Н. А. Никитин, С. М. Минин, E.V. Fisher, I.L. Mikheenko, A.M. Chernyavskiy, А. Б. Романов

    The role of epicardial adipose tissue (EAT) in the pathogenesis and prognosis of cardiovascular diseases has been actively discussed. This review provides information regarding the main mechanisms by which EAT influences the pathophysiology of rhythm disturbances, such as atrial fibrillation and ventricular arrhythmias, as well as their relationship with chronic heart failure. The pathogenesis of cardiac arrhythmias is exceedingly complex. As such, the mechanism by which EAT influences arrhythmias and heart failure can vary according to the anatomy and type of arrhythmia, one of which involves the autonomic nervous system (ANS). Some studies have shown a good treatment effects by targeting EAT in atrial fibrillation, whereas others have found that EAT volume can be used to predict the efficacy of radiofrequency ablation, a method for treating atrial fibrillation and ventricular arrhythmias. However, no standards have yet been established for the use of EAT visualisation. Fundamental, translational and clinical research are needed to study the role of EAT and ANS in the pathogenesis of cardiovascular diseases.Received 15 March 2021. Revised 25 April 2021. Accepted 26 April 2021.Funding: The work is supported by a grant of the Russian Science Foundation (project No. 17-75-20118).Conflict of interest: The authors declare no conflicts of interests.Contribution of the authorsConception and study design: D.V. Losik, N.A. Nikitin, S.M. Minin, A.B. Romanov, A.M. ChernyavskiyDrafting the article: D.V. Losik, I.L. Mikheenko, E.V. Fisher, N.A. NikitinCritical revision of the article: D.V. Losik, I.L. Mikheenko, E.V. Fisher, N.A. NikitinFinal approval of the version to be published: D.V. Losik, N.A. Nikitin, S.M. Minin, E.V. Fisher, I.L. Mikheenko, A.M. Chernyavskiy, A.B. Romanov


  • Open Access

    Modern possibilities of cardiovascular imaging using gamma cameras with cadmium–zinc–telluride-detectors

    by С. М. Минин, K. Zavadovky, Н. А. Никитин, А. В. Мочула, А. Б. Романов, К. В. Завадовский

    Myocardial perfusion imaging is considered one of the leading non-invasive diagnostic tools for the assessment of patients with known or suspected coronary artery disease and other cardiac pathologies. The technical improvement of the currently used gamma-tomographic devices has increased the diagnostic capability of this technique. In recent years, the use of dedicated cardiac SPECT cameras with solid-state cadmium–zinc–telluride (CZT) technology has increased in nuclear imaging. These new CZT technologies have several advantages over existing scanner models. The development of new CZT detectors and their collimator configuration has increased scanning sensitivity and spatial resolution values. Also, due to the significantly higher sensitivity of new CZT detectors and new methods of data processing, radiologists have already introduced new scanning protocols and methods for radionuclide assessment of myocardial blood flow, reserve and non-invasive visualisation of the functioning of the sympathetic nervous system into clinical practice. The purpose of this review is to provide data on the main technical characteristics of gamma cameras equipped CZT detectors as well as the current possibilities of using CZT cameras for examining patients with various cardiovascular diseases.Received 1 April 2020. Revised 22 April 2020. Accepted 30 April 2019.Funding: The work is supported by a grant of the Russian Science Foundation No. 17-75-20118.Conflict of interest: Authors declare no conflict of interest.Author contributionsConception and study design: S.M. Minin, K.V. Zavadovky, A.B. RomanovDrafting the article: S.M. Minin, K.V. Zavadovky, N.A. Nikitin, A.V. Mochula, A.B. RomanovCritical revision of the article: S.M. Minin, K.V. ZavadovkyFinal approval of the version to be published: S.M. Minin, K.V. Zavadovky, N.A. Nikitin, A.V. Mochula, A.B. Romanov